Nicorette Bucomist (Nicotine)

Nicotine, the active ingredient in Nicorette Bucomist, is a nicotine replacement therapy presented as an oromucosal product for buccal use. The formulation is designed for convenient placement in the mouth, allowing nicotine absorption through the oral mucosa. It is intended to aid adult smokers who wish to quit by delivering controlled nicotine to lessen withdrawal symptoms and cravings.

GNH USA supplies Nicorette Bucomist as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Nicorette Bucomist is a nicotine replacement therapy that addresses tobacco dependence and supports smoking cessation.

- Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms. - Tobacco dependence: provides a controlled nicotine source to replace cigarettes during the quitting process. - Relapse prevention: assists individuals who have stopped smoking to maintain abstinence by managing occasional urges.

Nicorette Bucomist may cause a range of oral and systemic reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Mouth irritation or soreness - Throat irritation - Nausea - Hiccups - Headache

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Severe mouth ulceration

When considering Nicorette Bucomist, several safety measures should be observed to minimize risks.

- Assess nicotine dependence: evaluate the patient’s smoking history and level of addiction before initiating therapy. - Avoid use in recent myocardial infarction: contraindicated in patients who have experienced a heart attack within the past 2 weeks. - Do not combine with other nicotine products: concurrent use may increase nicotine exposure and adverse effects. - Monitor blood pressure in hypertensive patients: nicotine can transiently raise blood pressure and heart rate. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotine can influence the activity of several drugs; interactions are classified by clinical significance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate nicotine’s cardiovascular effects. - Certain antidepressants (e.g., bupropion): combined use can increase the risk of seizures.

Moderate Interactions (Monitor Closely): - Warfarin: nicotine may affect INR; monitor coagulation parameters. - Theophylline: nicotine can alter metabolism, requiring level checks. - Insulin or oral hypoglycemics: nicotine may affect glucose control; monitor blood sugar.